Document Detail


Cardiovascular risk assessment with oxidised LDL measurement in postmenopausal women receiving intranasal estrogen replacement therapy.
MedLine Citation:
PMID:  20670096     Owner:  NLM     Status:  In-Data-Review    
Abstract/OtherAbstract:
Objective. To investigate the effect of intranasal estrogen replacement therapy administered to postmenopausal women alone or in combination with progesterone on markers of cardiovascular risk. Methods. The study was conducted with 44 voluntary postmenopausal women. In group I (n = 15), the patients were treated with only intranasal estradiol (300 μg/day estradiol hemihydrate). In group II (n = 11), the patients received cyclic progesterone (200 mg/day micronized progesterone) for 12 days in each cycle in addition to continuous intranasal estradiol. Group III (n = 18) was the controls. Serum lipid profiles, oxidised low-density lipoprotein (LDL) and other markers of cardiovascular risk were assessed at baseline and at the 3rd month of the treatment. Results. Lipid profile, LDL apolipoprotein B, lipoprotein a, homocysteine, oxidised LDL values and oxidised LDL/LDL cholesterol ratio were not observed to change after 3 months compared to baseline values within each group (p > 0.016). In comparison to changes between the groups after the treatment, only oxidised LDL levels and oxidised LDL/LDL cholesterol ratios of group II were increased compared to control group (p < 0.05). Conclusions. Intranasal estradiol alone did not appear to have an effect on markers of cardiovascular risk in healthy postmenopausal women. However, the addition of cyclic oral micronized progesterone to intranasal estradiol influenced the markers of cardiovascular risk negatively in comparison to non-users in healthy postmenopausal women.
Authors:
Mertihan Kurdoglu; Mulazim Yildirim; Zehra Kurdoglu; Ahmet Erdem; Mehmet Erdem; Ayse Bilgihan; Bulent Goktas
Related Documents :
19113906 - Lipid levels: a link between cardiovascular disease and osteoporosis?
15119506 - Global cardiovascular risk evaluation in italy: a cross-sectional survey in general pra...
23458066 - Diabetic population mortality and cardiovascular risk attributable to hypertension: a d...
9009976 - Relationship of distance run per week to coronary heart disease risk factors in 8283 ma...
21753066 - Adolescent dairy product consumption and risk of type 2 diabetes in middle-aged women.
14747686 - Vitamin intake is not associated with community-acquired pneumonia in u.s. men.
Publication Detail:
Type:  Journal Article     Date:  2010-07-29
Journal Detail:
Title:  Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology     Volume:  27     ISSN:  1473-0766     ISO Abbreviation:  Gynecol. Endocrinol.     Publication Date:  2011 Aug 
Date Detail:
Created Date:  2011-07-05     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  8807913     Medline TA:  Gynecol Endocrinol     Country:  England    
Other Details:
Languages:  eng     Pagination:  1-7     Citation Subset:  IM    
Affiliation:
Department of Obstetrics and Gynaecology, Yuzuncu Yil University School of Medicine, Van, Turkey (Formerly, Department of Obstetrics and Gynaecology, Gazi University School of Medicine, Ankara, Turkey).
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  High mean platelet volume, low-grade systemic coagulation, and fibrinolytic activation are associate...
Next Document:  How do levonorgestrel-only emergency contraceptive pills prevent pregnancy? Some considerations.